These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16418398)

  • 1. CCR5 deficiency increases risk of symptomatic West Nile virus infection.
    Glass WG; McDermott DH; Lim JK; Lekhong S; Yu SF; Frank WA; Pape J; Cheshier RC; Murphy PM
    J Exp Med; 2006 Jan; 203(1):35-40. PubMed ID: 16418398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.
    Lim JK; Louie CY; Glaser C; Jean C; Johnson B; Johnson H; McDermott DH; Murphy PM
    J Infect Dis; 2008 Jan; 197(2):262-5. PubMed ID: 18179388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic basis for human susceptibility to West Nile virus.
    Diamond MS; Klein RS
    Trends Microbiol; 2006 Jul; 14(7):287-9. PubMed ID: 16750369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.
    Lim JK; McDermott DH; Lisco A; Foster GA; Krysztof D; Follmann D; Stramer SL; Murphy PM
    J Infect Dis; 2010 Jan; 201(2):178-85. PubMed ID: 20025530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 limits cortical viral loads during West Nile virus infection of the central nervous system.
    Durrant DM; Daniels BP; Pasieka T; Dorsey D; Klein RS
    J Neuroinflammation; 2015 Dec; 12():233. PubMed ID: 26667390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection.
    Lim JK; Glass WG; McDermott DH; Murphy PM
    Trends Immunol; 2006 Jul; 27(7):308-12. PubMed ID: 16753343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.
    Glass WG; Lim JK; Cholera R; Pletnev AG; Gao JL; Murphy PM
    J Exp Med; 2005 Oct; 202(8):1087-98. PubMed ID: 16230476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A moving target: the multiple roles of CCR5 in infectious diseases.
    Klein RS
    J Infect Dis; 2008 Jan; 197(2):183-6. PubMed ID: 18179384
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood group A and D negativity are associated with symptomatic West Nile virus infection.
    Kaidarova Z; Bravo MD; Kamel HT; Custer BS; Busch MP; Lanteri MC
    Transfusion; 2016 Jul; 56(7):1699-706. PubMed ID: 27189860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
    Thio CL; Astemborski J; Bashirova A; Mosbruger T; Greer S; Witt MD; Goedert JJ; Hilgartner M; Majeske A; O'Brien SJ; Thomas DL; Carrington M
    J Virol; 2007 Jan; 81(2):441-5. PubMed ID: 17079285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.
    Ellwanger JH; Kulmann-Leal B; Kaminski VL; Rodrigues AG; Bragatte MAS; Chies JAB
    Virus Res; 2020 Sep; 286():198040. PubMed ID: 32479976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 deficiency and severe polio infection in the 1984 outbreak in Finland.
    Rosenberg AS; Roivainen M; Hovi T; Liu Q; Murphy PM
    J Med Virol; 2013 Dec; 85(12):2139-40. PubMed ID: 24037958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
    Iversen AK; Christiansen CB; Attermann J; Eugen-Olsen J; Schulman S; Berntorp E; Ingerslev J; Fugger L; Scheibel E; Tengborn L; Gerstoft J; Dickmeiss E; Svejgaard A; Skinhøj P
    J Infect Dis; 2003 Jan; 187(2):215-25. PubMed ID: 12552446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
    Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY; Togni M; Widmer U
    Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
    Lim JK; Lisco A; McDermott DH; Huynh L; Ward JM; Johnson B; Johnson H; Pape J; Foster GA; Krysztof D; Follmann D; Stramer SL; Margolis LB; Murphy PM
    PLoS Pathog; 2009 Feb; 5(2):e1000321. PubMed ID: 19247438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.